Dirençli migren tedavisi sonrası gelişen propofol bağımlılığı

Propofol hızlı sedatif etki gösteren oldukça potent  intravenöz uygulanan anestetik bir ajandır. Son zamanlarda refrakter başağrılarında bir tedavi seçeneği olarak kullanılmaya başlanmıştır. Bu vakada 38 yaşında bayan hastada refrakter başağrıları nedeniyle propofol tedavisi uyganmış ve propofole karşı bağımlılık gelişmiştir. Propofol tedavisinin kesilmesi ile hastada çok şiddetli çekilme belirtileri gözlenmiş ve tedavi başlanmıştır.Son yıllarda propofolün bağımlılık yapıcı etkisi, kötüye kullanım potansiyeli ve sonuç olarak intihar girişimi olan vakalarla sık karşılaşılmaktadır. Refrakter başağrılarında intravenöz propofol tedavisi oldukça etkili olmakla beraber bağımlılık yapıcı etkisi ve kötüye kullanımı mutlaka göz önünde bulundurulmalıdır.

Propofol addiction after treatment of refractory migraine

Propofol is a potent intravenous anesthetic agent that rapidly induces sedation. Recently it has been considered as a treatment option for refractory headaches.We report a case of 38 years of female who has received propofol treatment for her refractory headaches and severe dependence on propofol has occured. She had excessive withdrawal symptoms after discontinuing propofol and was succesfully treated. The abuse and dependency potential of propofol has recently been recognized and several cases of suicide have emerged. Although intravenous propofol is an efficacious treatment for patients with refractory headaches, the severe dependency and abuse potential must be taken into consideration.

___

  • 1. Marik PE. Propofol:therapeutic indications and side-effects. Curr Pharm Des. 2004;10:3639-49
  • 2. Schneider U, Rada D, Rollnik JD, Passie T, Emrich HM. Propofol dependency after treatment of tension headache. Addict Biol. 2001;6:263-5.
  • 3. Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40:224-30.
  • 4. Plummer PN, Colson NJ, Lewohl JM, MacKay RK, Fernandez F, Haupt LM et al. Significant differences in gene expression of GABA receptors in peripheral blood leukocytes of migraineurs. Gene. 2011;490:32-6.
  • 5. Cha HJ, Cha JH, Cho HY, Chung EY, Kwon KJ, Lee JY et al. Dependence potential of propofol: behavioral pharmacology in rodents. Biomol Ther (Seoul). 2012;20:234-8.
  • 6. Tezcan AH, Ornek DH, Ozlu O, Baydar M, Yavuz N, Ozaslan NG et al. Abuse potential assessment of propofol by its subjective effects after sedation. Pak J Med Sci. 2014;30:1247-52.
  • 7. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol. 2007;21:459-66.
  • 8. Luck S, Hedrick J. The alarming trend of substance abuse in anaesthesia providers. J. Perianesth. Nurs. 2004;19:308-11.
  • 9. Snow V, Weiss K, Wall EM, Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137:840-9.
  • 10. Drummond-Lewis J, Scher C.Propofol: a new treatment strategy for refractory migraine headache. Pain Med. 2002;3:366-9.
  • 11. Soleimanpour H, Taheraghdam A, Ghafouri RR, Taghizadieh A, Marjany K, Soleimanpour M. Improvement of refractory migraine headache by propofol: case series. Int J of Emerg Med. 2012;5:19.
  • 12. Bloomstone JA. Propofol: a novel treatment for breaking migraine headache. Anesthesiology. 2007 ;106:405-6.
  • 13. Mendes PM, Silberstein SD, Young WB, Rozen TD, Paolone MF. Intravenous propofol in the treatment of refractory headache. Headache. 2002;42:638-41.
  • 14. Zacny JP, Lichtor JL, Coalson DW, Finn RS, Uitvlugt AM, Glosten B et al. Subjective and psychomotor effects of subanesthetic doses of propofol in healthy volunteers. Anesthesiology. 1992;76:696-702.
  • 15. Zhao Y, Sun L. Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function. J Clin Neurosci. 2008;15:1264-9
  • 16. Roh S, Park JM, Kim DJ. A case of propofol dependence after repeated use for endoscopy. Endoscopy. 2011;43 Suppl 2 UCTN:E362.
  • 17. Bonnet U, Banger M, Leweke FM, Specka M, Muller BW, Hashemi T et al. Treatment of acute alcohol withdrawal with gabapentin results from a controlled two center trial. J Clin Psychopharmacol. 2003;23;514-9.
Cukurova Medical Journal-Cover
  • ISSN: 2602-3032
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1976
  • Yayıncı: Çukurova Üniversitesi Tıp Fakültesi